ArticleFrontiers in endocrinology2025
Association between pretransfer cleavage-stage blastomere dynamics and pregnancy outcomes in fresh single embryo transfer cycles: a retrospective cohort study.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
- Commented on by
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the impact of embryo blastomere cell number and dynamic changes in cell number during the morning of embryo transfer day (7:00-11:00) on clinical pregnancy outcomes in fresh single embryo transfer (SET) cycles. Methods: A retrospective cohort study was performed, including 561 fresh SET cycles conducted between January 2022 and June 2024. Cycles were categorized into four groups based on embryo blastomere count before transfer: ≤7-cell, 8-cell, 9-10-cell, and ≥11-cell groups. We analyzed the relationship between the increase in blastomere number observed from 7:00 a.m. to 11:00 a.m. on the day of transfer and clinical pregnancy outcomes. Multivariate logistic regression analysis was utilized to assess the influence of various factors on clinical pregnancy and live birth rates. Results: Clinical pregnancy rates significantly differed among the ≤7-cell, 8-cell, 9-10-cell, and ≥11-cell groups (10.64%, 36.69%, 42.31%, and 46.32%, respectively; P = 0.004). Live birth and biochemical pregnancy rates exhibited a similar increasing trend with higher cell numbers (P = 0.001), whereas early miscarriage rates showed no significant differences among groups (P = 0.157). In the 9-10-cell group, embryos that exhibited an increase in blastomere number had significantly higher clinical pregnancy rates (50% vs. 23.68%, P = 0.006) and live birth rates (41.30% vs. 15.79%, P = 0.005). No significant differences were observed in the ≤7-cell and 8-cell groups (P > 0.05). Multivariate logistic regression analysis demonstrated that increased endometrial thickness significantly improved clinical pregnancy likelihood (P = 0.034), whereas lower blastomere number (≤7-cell) significantly reduced clinical pregnancy rates (P = 0.002). Conclusion: A higher embryo blastomere count before transfer is significantly associated with improved clinical pregnancy and live birth outcomes in fresh SET cycles. Short-term increases in blastomere number on the morning of transfer day may reflect superior embryo developmental potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.